Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis | MicrobiomeTrials
Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2004-09Est. Completion: 2008-12
Enrollment target: 112 participants
Locations
Hopital du haut Leveque, Pessac, France
Other microbiome trials you might be interested in